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Objectives: Relevance of training has been recognized
as a key factor for safety of Carotid stenting (CAS).
The objective of this study was to evaluate whether the
center learning curve could shortcut the training of new
trainees with CAS.
Methods: Consecutive CAS procedures performed
from 2001 to 2010 were reviewed. The learning curve
phase (years 2001-2003) was performed by the “leader
team” (“historical team”) including vascular surgeons
and interventional radiologists who first approached
CAS. Learning curve included acquisition of handle skill
with CAS procedural steps and best selection of patients
and materials. Periprocedural complications after the
learning curve in the “leader team phase” (the historical
team continued to perform all procedures in 2004-2006)
and in the “expanded team phase” (5 new trainees joined
the historical team in 2006-2010) were measured.
Results: A total of 1540 CAS were reviewed. The first
195 represented the learning curve. Of the remaining 1345
CAS, 431 were performed in the “leader phase” and 914 in
the “expanded team phase”. Individual operator volume
for the new trainees ranged from 20 to 188 CAS. Peripro-
cedural complications were similarly low in the two phases:
strokes (2.8% vs 2.2%; P  .56) major strokes (0.9% vs
0.8%, P  .75), death (0.2% vs 0%; P  .3) for the leader
and expanded team phase respectively. Mean procedure
time was longer (43 min vs 38 min) in the expanded team
phase, while rates of immediate conversions (1.0% vs
3.5%, P  .03) and mean contrast use (69mL vs 92mL;
P .0001) decreased.
Conclusions: The primary factor driving stroke reduc-
tion with CAS is the center experience. CAS complication
rate is not based on individual rules but most likely on the
center/team practice also defining how to select patients
and materials best suited for the procedure. Appropriate
learning curve of the center can reliably shortcut the train-
ing of new trainees preserving CAS safety and efficacy.
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Objectives: The purpose of this study was to evaluate
the impact of gender on late functional outcomes of lower
extremity bypass (LEB).
Methods: We reviewed 3,301 patients (1,060; 32%
females) undergoing LEB in the Vascular Surgery Group of
New England from January 2003 to June 2010 to assess
procedural outcomes, independent living, and ambulatory
status according to preoperative baseline. Logistic regres-
sion models adjusted for differences between genders and
potential confounders (age, race, smoking, indication, pre-
operative ambulation, statin use, conduit, and length of
follow up). Ambulation and living status were analyzed by
life table analysis.
Results: On univariate analysis woman had less CAD
(35% vs. 40 %, P.001), smoking (75% vs. 89%, P .002),
and autogenous conduits (63% vs. 71%, P.001). Women
had higher rates of reoperation for thrombosis (4% vs. 2%;
OR 2.09, P .001) or infection (2% vs. 1%; OR 2.36, P 
.02) without differences in graft patency (94% vs. 95%; P
.25) or mortality (2.1% vs. 2.1%; P  .84) at discharge.
Multivariate analysis showed fewer women were discharged
home (63% vs. 73%; OR 0.72, P.001) and ambulating at
discharge (90% vs. 93%; OR 0.65, P  .009) regardless of
preoperative ambulation. At long-term follow-up fewer
women lived independently (HR 1.46, P  .06) and sig-
nificantly fewer were ambulatory (HR 1.65, P  .004)
(Fig).
Conclusions: Women have similar procedural-related
complications but slightly inferior early and late functional
outcomes after LEB. These findings may help define phy-
sician and patient expectations in women before revascular-
ization.
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Protamine Sulfate Use Does Not Lower Hemorrhagic
Complications in Lower Extremity Bypass (LEB)
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Boston, MA
Objectives: Protamine Sulfate (PS) use in LEB is
highly variable. We sought to evaluate whether our selec-
tive use of PS was associated with hemorrhagic or throm-
botic complications following LEB.
Methods: All LEB in our institutional registry for occlu-
sive disease from 1/05-7/11were included. 519 LEB under-
went 1:1 propensity score matching to create similar PS and
no-PS cohorts. The primary endpoint was a composite of
hemorrhagic complications (hematoma, re-op for bleeding,
transfusion). 30-day graft patency was a secondary endpoint.
Results: 358 matched bypasses were analyzed: 179 re-
ceived PS and 179 did not. The propensity matched groups
were similar across all assessed variables (Table). By univariate
analysis, the PS and no-PS groups had similar rates of postop
hematoma (5.6% vs 3.3%, P .44), re-exploration for bleed-
ing (1.7% vs 1.1%, P .84), transfusion (20.1% vs 18.4%, P
.79), and composite ”any-bleeding complication” (24.6% vs
20.7%, P  .45). Each group had a similar 30-day primary
patency rate of 96%. By multivariable analysis, PS use did not
reduce hemorrhagic complications (OR0.8;95%CI0.48-1.3;
P  .35) and was not associated with loss of primary patency
(HR 0.72;95% CI 0.49-1.05; P  .1).
Conclusions: This propensity matched analysis dem-
onstrates that while selective use of PS was not protective
against hemorrhagic complications, it appears safe for use
even in grafts at higher risk of thrombosis.
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Objectives: 30-day URA after LEB is large cost-bur-
den and a target for cost containment strategies. We under-
took this study to identify factors associated with URA after
LEB.
Methods: This is a retrospective analysis from a pro-
spective institutional registry. All LEBs for occlusive disease
from 1/95-7/11 were included. The primary endpoint was
30-day URA.
Results: Of 1543 LEBs, 27 patients (1.7%) died in
house and were excluded. Of 1516 remaining LEBs,
84.5% were for CLI and 349 (23.0%) had 30-day URA.
Univariate predictors of URA are shown in the Table. By
multivariable analysis, pre-operative factors predictive of
URA were: Dialysis (OR 1.73, P  .004), Tissue loss
(OR 1.62, P  .0004), and CHF (OR 1.43, P .03).
Postoperative predictors included: SFA inflow source
(OR 1.38, P  .016), wound infection (OR 8.30, P
.0001) in-hospital graft failure (OR 3.20, P .0001)
and MI (OR 1.96, P .04). Conduit type, LOS, and
discharge disposition did not predict URA. URA inde-
pendently predicted loss of assisted primary patency (HR
1.39, P  .01) and long-term limb loss (HR 1.68, P 
.001).
Conclusions: 30-day URA is frequent following LEB
(23%). It is essential to consider risk factors associated with
URA for quality improvement and equitable resource allo-
cation when disease-specific bundling strategies are being
derived.
Table. Baseline characteristics
Unmatched cohort Propensity matched cohort
No protamine(%)
N227(43.7)
Protamine
N292(56.3) P value
No Protamine(%)
N179(50)
Protamine(%)
N179(50) P
Mean age [StdDev] 68.5 [11.4] 69.4 [11.9] .29 69.1 [11.2] 69.0 [12.4] .74
White race 171 (75.3) 240 (82.2) .06 140 (78.2) 144 (80.4) .7
Diabetes mellitus 129 (56.8) 140 (47.9) .05 95 (53.1) 92 (51.4) .83
Critical limb ischemia indication 183 (80.6) 230 (78.8) .66 141 (78.8) 137 (76.5) .7
Preoperative Coumadin 40 (17.6) 72 (24.7) .07 38 (21.2) 40 (22.3) .9
Infrapopliteal target vessel 131 (57.7) 133 (45.5) .006 93 (51.9) 93 (51.9) .99
Any completion study 191 (84.1) 209 (71.6) .0007 149 (83.2) 147 (82.1) .89
”Good” runoff (2-3 vessel) 86 (37.9) 140 (47.9) .03 75 (41.9) 76 (42.5) .99
Prosthetic conduit 46 (20.3) 96 (32.9) .001 43 (24.0) 42 (23.5) .99
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 1S Abstracts 87S
